198 related articles for article (PubMed ID: 29062340)
21. Effect of haemodialysis on markers of bone turnover in children.
Waller S; Ridout D; Rees L
Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
[TBL] [Abstract][Full Text] [Related]
22. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
23. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls.
Cheng S; Tylavsky F; Kröger H; Kärkkäinen M; Lyytikäinen A; Koistinen A; Mahonen A; Alen M; Halleen J; Väänänen K; Lamberg-Allardt C
Am J Clin Nutr; 2003 Sep; 78(3):485-92. PubMed ID: 12936933
[TBL] [Abstract][Full Text] [Related]
24. [CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].
Polak-Jonkisz D; Zwolińska D; Nahaczewska W
Pediatr Endocrinol Diabetes Metab; 2010; 16(1):25-8. PubMed ID: 20529602
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.
Douthat WG; Castellano M; Berenguer L; Guzmán MA; de Arteaga J; Chiurchiu CR; Massari PU; Garay G; Capra R; de La Fuente JL
Nefrologia; 2013; 33(5):657-66. PubMed ID: 24089157
[TBL] [Abstract][Full Text] [Related]
26. Associations of plasma fibroblast growth factor 23 and other markers of chronic kidney disease-Mineral and bone disorder with all-cause mortality in South African patients on maintenance dialysis: A 3-year prospective cohort study.
Waziri B; Musenge E; Duarte R; Dickens C; Dix-Peek T; Rekhviashvili V; Paget G; Naicker S
PLoS One; 2019; 14(5):e0216656. PubMed ID: 31107896
[TBL] [Abstract][Full Text] [Related]
27. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
Liu Y; He Q
Clin Lab; 2015; 61(7):839-43. PubMed ID: 26299086
[TBL] [Abstract][Full Text] [Related]
28. No effect of vitamin K1 supplementation on biochemical bone markers in haemodialysis patients.
Reichel H
Nephrol Dial Transplant; 1999 Jan; 14(1):249-50. PubMed ID: 10052531
[No Abstract] [Full Text] [Related]
29. Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction.
Lai JC; Bikle DD; Lizaola B; Hayssen H; Terrault NA; Schwartz JB
Liver Int; 2015 Oct; 35(10):2294-300. PubMed ID: 25757956
[TBL] [Abstract][Full Text] [Related]
30. Oral activated charcoal suppresses hyperphosphataemia in haemodialysis patients.
Wang Z; Cui M; Tang L; Li W; Wei Y; Zhu Z; Jia X; Kong X; Xu D
Nephrology (Carlton); 2012 Sep; 17(7):616-20. PubMed ID: 22697887
[TBL] [Abstract][Full Text] [Related]
31. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines.
Liu Y; Lee WC; Cheng BC; Li LC; Lee CH; Chang WX; Chen JB
Biomed Res Int; 2016; 2016():1523124. PubMed ID: 28003998
[No Abstract] [Full Text] [Related]
32. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
Avila M; Prado C; Ventura MD; Mora C; Briones D; Valdez H; Hurtado ME; Lindholm B; Qureshi A; Castillo-Henkel C; Paniagua R
Nephrol Dial Transplant; 2010 Jul; 25(7):2259-65. PubMed ID: 20124547
[TBL] [Abstract][Full Text] [Related]
34. Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study.
Fernström A; Giæver J; Granroth B; Hylander B; Jensen G; Christensson A; Wikström B; Weiss L; Wrege U; Jacobson SH
Scand J Urol Nephrol; 2011 Apr; 45(3):196-205. PubMed ID: 21366390
[TBL] [Abstract][Full Text] [Related]
35. Hyperparathyroid bone disease in diabetic renal failure.
Cundy TF; Humphreys S; Watkins PJ; Parsons V
Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
[TBL] [Abstract][Full Text] [Related]
36. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
37. Low bone mineral density in adult patients with coeliac disease.
Szymczak J; Bohdanowicz-Pawlak A; Waszczuk E; Jakubowska J
Endokrynol Pol; 2012; 63(4):270-6. PubMed ID: 22933162
[TBL] [Abstract][Full Text] [Related]
38. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
[TBL] [Abstract][Full Text] [Related]
39. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
Zehnder D; Landray MJ; Wheeler DC; Fraser W; Blackwell L; Nuttall S; Hughes SV; Townend J; Ferro C; Baigent C; Hewison M
Nephron Clin Pract; 2007; 107(3):c109-16. PubMed ID: 17890873
[TBL] [Abstract][Full Text] [Related]
40. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays].
Ureña P; Prieur P; Pétrover M
Presse Med; 1996 Oct; 25(29):1320-5. PubMed ID: 8942941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
